Macquarie Group Ltd

SEC CIK: 0001418333
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

ALGS holding history

Aligos Therapeutics, Inc. in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALGS overview All 13F holders of ALGS Full Q2 2026 holdings

Shares (Q2 2022): 0; Sold out in Q2 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q3 2021

Holdings of ALGS by Macquarie Group Ltd, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	0	$0	0.0%	−4,417−100.0%	Sold out	Holders
Q1 2022	4,417	$9.00K	<0.1%	00.0%	Unchanged	Holders
Q4 2021	4,417	$52.0K	<0.1%	−1,369−23.7%	Reduced	Holders
Q3 2021	5,786	$90.0K	<0.1%	+5,786	New	Holders